Prothena reported -37744000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -102.62M 13.68M
Nektar Therapeutics NKTR:US $ -109.47M 0.5M
Vital Therapies VTL:US $ -21.41M 0.26M
Xoma XOMA:US $ -2063000 32.43M